PNC Financial Services Group Inc. Purchases 1,465 Shares of West Pharmaceutical Services Inc. (WST)
PNC Financial Services Group Inc. lifted its position in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 6.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 23,779 shares of the medical instruments supplier’s stock after acquiring an additional 1,465 shares during the period. PNC Financial Services Group Inc.’s holdings in West Pharmaceutical Services were worth $2,936,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in WST. Twin Capital Management Inc. acquired a new stake in West Pharmaceutical Services in the 3rd quarter valued at about $494,000. MML Investors Services LLC acquired a new stake in West Pharmaceutical Services in the 3rd quarter valued at about $372,000. Rhumbline Advisers lifted its holdings in West Pharmaceutical Services by 3.2% in the 3rd quarter. Rhumbline Advisers now owns 185,771 shares of the medical instruments supplier’s stock valued at $22,937,000 after acquiring an additional 5,710 shares during the last quarter. Prudential Financial Inc. lifted its holdings in West Pharmaceutical Services by 145.2% in the 3rd quarter. Prudential Financial Inc. now owns 218,492 shares of the medical instruments supplier’s stock valued at $26,977,000 after acquiring an additional 129,400 shares during the last quarter. Finally, SG Americas Securities LLC lifted its holdings in West Pharmaceutical Services by 79.7% in the 3rd quarter. SG Americas Securities LLC now owns 19,228 shares of the medical instruments supplier’s stock valued at $2,374,000 after acquiring an additional 8,530 shares during the last quarter. Institutional investors and hedge funds own 92.50% of the company’s stock.
WST stock opened at $106.02 on Friday. The company has a quick ratio of 2.23, a current ratio of 2.94 and a debt-to-equity ratio of 0.15. West Pharmaceutical Services Inc. has a one year low of $82.74 and a one year high of $125.09. The stock has a market cap of $8.09 billion, a price-to-earnings ratio of 38.14, a PEG ratio of 4.09 and a beta of 1.19.
A number of equities research analysts have weighed in on the stock. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Saturday, November 17th. ValuEngine raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating in a report on Wednesday, October 17th.
TRADEMARK VIOLATION WARNING: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.dailypolitical.com/2018/12/08/pnc-financial-services-group-inc-purchases-1465-shares-of-west-pharmaceutical-services-inc-wst.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
See Also: Cost of Equity
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.